Healios K.K. (HLOSF)
OTCMKTS · Delayed Price · Currency is USD
2.100
+0.170 (8.81%)
At close: Jan 16, 2026
Healios K.K. Market Cap
Healios K.K. has a market cap or net worth of $283.83 million as of February 12, 2026. Its market cap has increased by 109.44% in one year.
Market Cap
283.83M
Enterprise Value
258.71M
Revenue
655.45K
Ranking
n/a
PE Ratio
n/a
Stock Price
$2.10
Market Cap Chart
Since June 16, 2015, Healios K.K.'s market cap has decreased from 543.57M to 283.83M, a decrease of -47.78%. That is a compound annual growth rate of -5.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 285.45M | 41.02% |
| Dec 30, 2025 | 202.43M | 99.43% |
| Dec 30, 2024 | 101.50M | 16.33% |
| Dec 29, 2023 | 87.26M | -30.42% |
| Dec 30, 2022 | 125.40M | -79.59% |
| Dec 30, 2021 | 614.50M | -37.54% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 399.44M |
| CytoDyn | 311.51M |
| Silence Therapeutics | 211.61M |
| Vaxart | 145.24M |
| HST Global | 139.70M |
| BioStem Technologies | 105.50M |
| Nuo Therapeutics | 80.63M |
| VitaSpring Biomedical | 51.78M |